Michelle Acosta & Honoria Guarino
Opioid use disorders (OUD) are present in approximately 2.6 million Americans, at an estimated annual cost of $55 billion, with escalation in rates of OUD being most pronounced among youth. Many young opioid users demonstrate a rapid transition to injection drug use (IDU), which is associated with significant risks (e.g., overdose, HIV/HCV); yet there is virtually no research on how to prevent or halt this transition. Our proposed mHealth intervention to prevent progression to IDU among young opioid users (18-29), may have tremendous impact on improving access, acceptability, and potency of opioid use interventions for youth.
For more information: Abstract